CClinicalTrials.gg
RecruitingNCT06037629PEACOCKUpdated Sep 14, 2023

Premature Enhanced Automated Capture of Comfort Knowledge

An observational study in Acute Pain, Pain, Procedural and Agitation, sponsored by Newcastle University. Recruiting at 1 site in United Kingdom. Open to participants aged Up to 37 Weeks. Per ClinicalTrials.gov, last updated 2023-09-14.

Sponsored by Newcastle University · Observational

From the registry’s dates

  • Primary completion was expected by Jan 2024, 2 years 9 months ago, but the record still lists the study as recruiting.
  • Started Feb 2023; still recruiting 3 years 8 months later.
Study type
Observational
Model
Other
Time perspective
Prospective
Enrollment
100
Ages
Up to 37 Weeks
Sex
All
01

Study summary

The goal of this observational study is to develop methods that could provide continual monitoring of comfort levels for preterm neonates in hospitals.

Read the detailed description

As preterm neonates have not developed ways to communicate how they are feeling like children or adults do, clinicians must rely on their own understanding and professional judgements to decide how comfortable they are. It is known that preterm neonates can display emotion through ways such as facial expressions, body movements and changes in their physiology such as heart rate. The investigators will record both behavioural (audiovisual) and physiologic (heart rate, blood oxygen saturation) signals during routine clinical procedures ranging from comforting, through discomforting to painful that are necessary as part of high-quality medical care.

02

Conditions studied

  • Acute Pain
  • Pain, Procedural
  • Agitation
  • Discomfort
03

In context

Acute Pain

876 studies on the registry are indexed under Acute Pain; 154 are open to participants now.

This study's planned enrollment of 100 is below the median of 150 across 113 observational studies indexed under Acute Pain.

Browse Acute Pain studies →

Lead sponsor

Newcastle University is the lead sponsor of 59 studies on the registry; 15 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Up to 37 Weeks
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Preterm neonates hospitalised in the Royal Victoria Infirmary Neonatal Intensive Care Unit

Inclusion criteria

  • Preterm Infants born \<36 completed weeks of gestation
  • Medically stable
  • Written informed consent from parents

Exclusion criteria

Exclusion Criteria:

  • Infants with significant brain, spine, or congenital abnormality
  • Parents unwilling to provide consent
  • Infants with postmenstrual age >36 weeks
05

Study design

Observational model
Other
Time perspective
Prospective
Enrollment
100 participants (estimated)
Patient registry
No

Groups and cohorts

  • Preterm neonates in intensive care

    Preterm neonates born \<36 completed weeks of gestation with postmenstrual age \<36 weeks

06

What researchers measure

Primary outcomes

  1. Pain Score Before Procedure

    Score provided by nurses from Neonatal Pain, Agitation \& Sedation Scale. Pain/Agitation scores range from 0-13, higher scores indicate higher pain/agitation levels.

    Time frame: 1 minute recording before procedure

  2. Audiovisual signal Before Procedure

    Bedside recording using camera and microphone.

    Time frame: 1 minute starting before procedure

  3. Physiologic Signal Before Procedure: Heart Rate

    Heart rate captured by bedside ECG monitor

    Time frame: 1 minute starting before procedure

  4. Physiologic Signal Before Procedure: Blood Oxygen Saturation

    Blood oxygen saturation captured by bedside oximetry monitor

    Time frame: 1 minute starting before procedure

  5. Pain Score During Procedure

    Score provided by nurses from Neonatal Pain, Agitation \& Sedation Scale. Pain/Agitation scores range from 0-13, higher scores indicate higher pain/agitation levels.

    Time frame: 1 minute recording during procedure

  6. Audiovisual Signal During Procedure

    Bedside recording using camera and microphone

    Time frame: 1 minute during procedure

  7. Physiologic Signal During Procedure: Heart Rate

    Heart rate captured by bedside ECG monitor

    Time frame: 1 minute during procedure

  8. Physiologic Signal During Procedure: Blood Oxygen Saturation

    Blood oxygen saturation captured by bedside oximetry monitor

    Time frame: 1 minute during procedure

  9. Pain Score After Procedure

    Score provided by nurses from Neonatal Pain, Agitation \& Sedation Scale. Pain/Agitation scores range from 0-13, higher scores indicate higher pain/agitation levels.

    Time frame: 1 minute recording immediately after procedure

  10. Audiovisual Signal After Procedure

    Bedside recording using camera and microphone

    Time frame: 1 minute immediately after procedure

  11. Physiologic Signal After Procedure: Heart Rate

    Heart rate captured by bedside ECG monitor

    Time frame: 1 minute immediately after procedure

  12. Physiologic Signal After Procedure: Blood Oxygen Saturation

    Blood oxygen saturation captured by bedside oximetry monitor

    Time frame: 1 minute immediately after procedure

07

Study locations

1 of 1 sites recruiting
  • The Newcastle Upon Tyne Hospitals Nhs Foundation Trust
    Newcastle upon Tyne, NE1 4LP, United Kingdom
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 14, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06037629
Lead sponsor
Newcastle University
Collaborators
Newcastle-upon-Tyne Hospitals NHS Trust
Responsible party
Arthur Howard (Principal Investigator, Newcastle University) — Principal investigator
First posted
Sep 14, 2023
Start date
Feb 1, 2023
Primary completion
Jan 2024 (estimated)
Completion
Jan 2024 (estimated)
Last update
Sep 14, 2023

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion